BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6951091)

  • 1. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
    Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
    J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potentiation of chemotherapeutic activity by a Chinese herb medicine juzen-taiho-toh].
    Komiyama K; Hirokawa Y; Zhibo Y; Umezawa I; Hata T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1715-9. PubMed ID: 3130806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of tumor immunity against syngeneic tumors in mice by beta-carotene.
    Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
    J Natl Cancer Inst; 1987 Apr; 78(4):679-81. PubMed ID: 3470543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological role of vitamin A and its related substances in prevention of cancer.
    Tomita Y
    Nutr Cancer; 1983; 5(3-4):187-94. PubMed ID: 6669479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potentiation of the therapeutic effect of chemotherapy and hyperthermia on experimental tumor and reduction of immunotoxicity of mitomycin C by juzen-taiho-toh, a Chinese herbal medicine].
    Komiyama K; Zhibo Y; Umezawa I
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):251-7. PubMed ID: 2493224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by vitamin A of the action of anticancer agents against murine tumors.
    Nakagawa M; Yamaguchi T; Ueda H; Shiraishi N; Komiyama S; Akiyama S; Ogata J; Kuwano M
    Jpn J Cancer Res; 1985 Sep; 76(9):887-94. PubMed ID: 3932288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines.
    Yoshida J; Takamura S; Yamaguchi N; Ren LJ; Chen H; Koshimura S; Suzuki S
    Jpn J Exp Med; 1989 Aug; 59(4):157-61. PubMed ID: 2601113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
    Iigo M; Kuretani K; Hoshi A
    Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma.
    Pavelic ZP; Dave S; Bialkowski S; Priore RL; Greco WR
    Cancer Res; 1980 Dec; 40(12):4617-21. PubMed ID: 7438095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic T-cell-mediated antitumor effect of levamisole against murine syngeneic fibrosarcoma.
    Gomi K; Morimoto M; Nomoto K
    Cancer Res; 1982 Oct; 42(10):4197-202. PubMed ID: 6980702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.
    Shoemaker JP
    Cancer Res; 1978 Sep; 38(9):2700-2. PubMed ID: 679173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
    Niederkorn J; Streilein JW; Shadduck JA
    Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
    Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
    Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice.
    Zeis M; Frenzke H; Schmitz N; Uharek L; Steinmann J
    Bone Marrow Transplant; 2002 Feb; 29(3):213-21. PubMed ID: 11859393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.